Expert Clinical Benchmarks

Expert Clinical Benchmarks (ECB) is a specialized data and analytics firm that provides clinical trial performance metrics and benchmarking services to the global pharmaceutical and biotechnology sectors. The company focuses on delivering granular insights into clinical trial cycle times, costs, and operational efficiency, enabling R&D leaders to compare their performance against industry peers. In 2012, ECB was acquired by Informa to bolster its Pharma Intelligence division, which has since evolved into Citeline and is now part of Norstella. Today, ECB's methodologies and data assets continue to support strategic decision-making and process optimization within the drug development lifecycle. By utilizing actual trial data rather than surveys, the company offers a high degree of accuracy for trial planning and resource allocation.